Searched for
ASTHMA DRUG DEMAND
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Fake mango alert: 3,800 kg of chemically made pulp seized in Pune. Know side effects & how to identify artificially ripened aam at homeMango Adulteration Alert: With the mango season in full swing, rising cases of mango adulteration in India have sparked serious food safety...
- Trump govt rolls out TrumpRx website for discounted drugs, Americans to get massive relief on prices of major medicines, Bevespi Aerosphere and Ozempic on the list; check pricesThe Trump administration launched TrumpRx.gov on Thursday (February 5, 2026), a website designed to help Americans purchase prescription dr...
- Cardiac drugs log highest sales in 2025 as NCD cases surgeHeart medicines led sales in 2025, a trend set to continue. Respiratory and anti-diabetes drugs followed. Cardiac drug sales grew 13%, with...
- Lupin to set up new facility in US with an investment of USD 250 mnDrug firm Lupin will establish a new manufacturing plant in Coral Springs, Florida. The investment totals USD 250 million over five years. ...
- NPPA hauled up for hiking drug pricesIndia's parliamentary committee criticized the drug pricing regulator for approving a 50% price increase on 11 drug formulations in October...
- Amid pollution woes, Asthma drug demand drives pharma retail market growth in NovemberIndia's pharmaceutical retail market rebounded in November with double-digit growth, fueled by increased demand for dermatological, cardiac...
- Prices of key drugs hiked by 50%India's National Pharmaceutical Pricing Authority (NPPA) has raised the ceiling price of 11 essential drugs by 50% to ensure their availabi...
- As monsoon takes hold, anti-infective, respiratory drugs' demand surgesMonsoon led to a surge in demand for respiratory, anti-infective, and anti-malarial products. The respiratory market saw a notable increase...
- Cipla net profit jumps 17.4% to Rs 1,178 crore in Q1FY25Drug maker Cipla reported a 17.4% year-on-year (YoY) jump in net profit to Rs 1,178 crore in Q1FY25, led by strong US, India and South Afri...
- EU approves Sanofi's Dupixent for 'smoker's lungs'Sanofi and Regeneron received EU approval for broader use of Dupixent in treating chronic obstructive pulmonary disease (COPD), a significa...
- Strike when it’s hot! 58% stocks from this sector defy crisis to double pricesThis outperformance came after an underperformance of four years.
- Raw material for party drug worth Rs 270 crore seized from GujaratPolice has also named the son of a former Congress MLA Bhavsinh Rathod, Kishorsinh as kingpin of the drug racket, who is yet to be arrested.
- Lupin challenges tuberculosis drug price fixed by National Pharmaceutical Pricing AuthorityLupin has challenged the maximum retail price fixed by the country’s drug price regulator for its anti-tuberculosis brands and a new asthma...
- Cipla receives notices from NPPA for alleged overchargingDrug firm Cipla said it has received notices from the drug price regulator National Pharmaceutical Pricing Authority allegedly for over-pri...
- HC asks Modi-Mundipharma to part-pay before appealAllahabad High Court has asked Delhi-based drug firm Modi-Mundipharma to deposit half of the Rs 41 crore it allegedly overcharged consumers...
- AstraZeneca first-quarter profit up 42 pcAstraZeneca posted a 42 per cent rise in first quarter net profit on Thursday, boosted by sales of its heart drug Toprol-XL in the United S...
- Antibiotics, pain killers,insulin get 3% cheaperMedicines sold at government-set prices have become cheaper by nearly 3% after the country’s drug price regulator ordered a price cut in th...
- Now, CEOs prefer Ayurvedic treatment to handle stressOver 40% of the CEOs are taking to ayurveda like naturopathy, massage, acupuncture and acupressure to handle stress. Corporate India bets b...
Load More
